Zymeworks Balance Sheet
NASDAQ: ZYMEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zymeworks financial position
At the end of fiscal 2025, Zymeworks reported total assets of $346.5 million, down 25.2% from a year earlier against total liabilities of $78.0 million. Shareholders' equity stood at $268.5 million, or 77.5% of assets. The company held $41.2 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.88, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Zymeworks balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 41.16M | 66.10M | 157.56M | 400.91M | 201.87M | 242.04M |
| Short-Term Investments | — | — | 216.77M | 91.32M | 50.74M | — |
| Receivables | 4.64M | 55.81M | 19.48M | 33.40M | 15.61M | — |
| Total Current Assets | 248.77M | 300.45M | 412.93M | 544.71M | 288.22M | — |
| Property, Plant & Equipment | 15.50M | 17.65M | 19.85M | 24.71M | 22.78M | — |
| Goodwill | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | — |
| Intangible Assets | 1.35M | 4.58M | 7.66M | 8.76M | 3.84M | — |
| Long-Term Investments | — | — | 82.15M | 886.00K | 886.00K | — |
| Total Assets | 346.53M | 463.09M | 580.88M | 648.73M | 389.13M | — |
| Accounts Payable | 4.40M | 3.90M | 6.21M | 7.86M | 5.17M | — |
| Total Current Liabilities | 42.32M | 88.29M | 55.76M | 95.63M | 71.85M | — |
| Total Liabilities | 78.03M | 124.32M | 116.07M | 155.77M | 140.04M | — |
| Shareholders' Equity | 268.50M | 338.77M | 464.81M | 492.96M | 249.09M | 409.92M |
| Retained Earnings | -953.16M | -830.34M | -677.44M | -558.76M | -683.10M | — |
| Net Cash (Debt) | 41.16M | 66.10M | 374.33M | 492.23M | 252.61M | 242.04M |
| Shares Outstanding | 74.64M | 68.96M | 70.12M | 63.06M | 46.63M | — |
This table shows 6 annual periods of Zymeworks's balance sheet, from FY 2025 back to FY 2020, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ZYME's reporting calendar. What is a balance sheet?